Profil
Patricia Zilliox currently works at Eyevensys SAS, as President & Chief Executive Officer and Acticor Biotech SAS, as Independent Director from 2023.
Dr. Zilliox also formerly worked at Foundation Fighting Blindness Clinical Research Institute, as Chief Executive Officer, Alcon Laboratories, Inc., as Senior Director-Clinical Pharma, and The Foundation Fighting Blindness, Inc., as Chief Drug Development Officer.
Postes actifs de Patricia Zilliox
| Sociétés | Poste | Début |
|---|---|---|
| ACTICOR BIOTECH | Directeur/Membre du Conseil | 26/01/2023 |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Develops non-viral gene therapy process for the treatment of ocular illnesses | Directeur Général | 12/12/2017 |
Anciens postes connus de Patricia Zilliox
| Sociétés | Poste | Fin |
|---|---|---|
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Corporate Officer/Principal | 01/01/2011 |
Foundation Fighting Blindness Clinical Research Institute
Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Provides investment services | Directeur Général | - |
The Foundation Fighting Blindness, Inc.
The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services Provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Health Technology |
The Foundation Fighting Blindness, Inc.
The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services Provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome | Commercial Services |
Foundation Fighting Blindness Clinical Research Institute
Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Provides investment services | Finance |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Develops non-viral gene therapy process for the treatment of ocular illnesses | Commercial Services |
Acticor Biotech SAS
Acticor Biotech SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of pharmaceutical products | Commercial Services |
















